MDS Stock Overview
Medical Disposables & Supplies Limited engages in the distribution of healthcare and consumer products in Jamaica.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Medical Disposables & Supplies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JA$2.27 |
| 52 Week High | JA$6.00 |
| 52 Week Low | JA$1.75 |
| Beta | -0.29 |
| 1 Month Change | -0.44% |
| 3 Month Change | -16.54% |
| 1 Year Change | -54.60% |
| 3 Year Change | -46.59% |
| 5 Year Change | -66.86% |
| Change since IPO | 8.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDS | JM Healthcare | JM Market | |
|---|---|---|---|
| 7D | 29.7% | -1.7% | -1.1% |
| 1Y | -54.6% | -19.5% | -3.5% |
Return vs Industry: MDS underperformed the JM Healthcare industry which returned -19.5% over the past year.
Return vs Market: MDS underperformed the JM Market which returned -3.5% over the past year.
Price Volatility
| MDS volatility | |
|---|---|
| MDS Average Weekly Movement | 13.8% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in JM Market | 15.9% |
| 10% least volatile stocks in JM Market | 4.6% |
Stable Share Price: MDS has not had significant price volatility in the past 3 months.
Volatility Over Time: MDS's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of JM stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 121 | Kurt Boothe | mdsja.com |
Medical Disposables & Supplies Limited engages in the distribution of healthcare and consumer products in Jamaica. The company operates through Pharmaceuticals, Medical, and Consumables segments. It provides pharmaceuticals, vaccines, injectables, hospital supplies, medical disposable items, medical sundries, consumer products, and beauty items.
Medical Disposables & Supplies Limited Fundamentals Summary
| MDS fundamental statistics | |
|---|---|
| Market cap | JA$597.37m |
| Earnings (TTM) | -JA$71.51m |
| Revenue (TTM) | JA$3.70b |
0.2x
P/S Ratio-8.4x
P/E RatioIs MDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDS income statement (TTM) | |
|---|---|
| Revenue | JA$3.70b |
| Cost of Revenue | JA$2.77b |
| Gross Profit | JA$927.32m |
| Other Expenses | JA$998.83m |
| Earnings | -JA$71.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 25.07% |
| Net Profit Margin | -1.93% |
| Debt/Equity Ratio | 115.2% |
How did MDS perform over the long term?
See historical performance and comparison